Durable treatments for the complex range of diseases affecting the central nervous system have long been an area of focus for the medical community. With advances in gene and cell therapy, there is a growing range of therapeutic strategies which may provide long awaited relief to myriad patient populations. This panel will review the state of development and clinical progress for these next-generation durable treatments for CNS conditions.